Hepatitis C prophylactic vaccine - InnogeneticsAlternative Names: ED 001
Latest Information Update: 22 Nov 2006
At a glance
- Originator Innogenetics
- Class Hepatitis C vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Hepatitis C
Most Recent Events
- 15 Jan 2003 Preclinical trials in Hepatitis C prevention in Belgium (unspecified route)